Article Information
History
- November 26, 2021.
Article Versions
- Version 1 (April 22, 2021 - 20:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lirong Cao1,2,
- Jingzhi Lou3,
- Hong Zheng1,2,
- Shi Zhao1,2,
- Chris Ka Pun Mok1,
- Renee Wan Yi Chan4,5,
- Marc Ka Chun Chong1,2,
- Zigui Chen6,
- Eliza Lai Yi Wong1,
- Paul Kay Sheung Chan6,
- Benny Chung-Ying Zee1,2,
- Eng Kiong Yeoh1 and
- Maggie Haitian Wang1,2,*
- 1JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong SAR, China
- 2CUHK Shenzhen Research Institute, Shenzhen, China
- 3Beth Bioinformatics Co. Ltd., Hong Kong SAR, China
- 4Department of Paediatrics, Chinese University of Hong Kong, Hong Kong SAR, China
- 5CUHK-UMCU Joint Research Laboratory of Respiratory Virus & Immunobiology, Chinese University of Hong Kong, Hong Kong SAR, China
- 6Department of Microbiology, Stanley Ho Centre for Emerging Infectious Diseases, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong SAR, China
- ↵*Correspondence:
Maggie Haitian Wang, email: maggiew{at}cuhk.edu.hk, JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong SAR, China.
Posted November 26, 2021.
Rapid evaluation of COVID-19 vaccine effectiveness against VOC/VOIs by genetic mismatch
